Physicians who meet with patients via direct to consumer telemedicine services are just as likely to prescribe antibiotics as those who conduct in-person visits, according to a study conducted by Rand ...

Last week, JAMA Internal Medicine published a two-page research letter by the Rand Corporation that played into a national conversation about the efficacy of telemedicine -- specifically Teladoc, a ...

However, Teladoc has not performed well since it reached its all-time high in early 2021, and since then, the stock is down by 96%. Is the telemedicine specialist finally attractive at current levels, ...

Teladoc's depressed valuation reflects justified skepticism, with lackluster growth, declining premium engagement, and mounting competitive threats from insurers and tech giants. Financial metrics ...

Teladoc Health is launching an employee assistance program as the virtual care giant looks to boost its mental healthcare offerings. The program, called Wellbound, includes online therapy through its ...

Bullish comments from a noted short-seller pushed shares of Teladoc Health (NYSE: TDOC) higher on Friday. The telemedicine ...

Like all companies, Teladoc Health (NYSE: TDOC) will need to evolve a lot over the next three years. The days of the telehealth operator's peak hype are now firmly in the past. It's up to management ...

As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the online marketplace industry, including Teladoc (NYSE:TDOC) and its peers.

Teladoc plans to be balanced on capital spending between investments within the firm — like spending on data and analytics and improving customer engagement with its suite of virtual care products — ...

Teladoc Health has dealt with decreased demand for its services and lower revenue growth. The company is betting on acquisitions and international expansion to turn things around. However, based on ...